Laser Therapy Reduced Glaucoma Eye Pressure
A two-year study shows that glaucoma patients may see lower eye pressure and lower medication needs after laser treatment.
Updated on Oct. 12, 2026 in Stroke
Live Poll
Do you generally trust the findings of independent clinical studies for new medical treatment options?
A recent study published in the International Journal of Ophthalmology found that MicroPulse laser therapy successfully lowered intraocular pressure over a 24-month period. The treatment also reduced the reliance on topical medications for patients with primary open-angle or angle-closure glaucoma.
Why it matters
For patients managing glaucoma, this development highlights a potential pathway to decrease the burden of daily topical medication routines while maintaining stable eye pressure. The findings suggest a durable treatment option that may help preserve visual field stability over time.
In a retrospective study of 84 eyes, researchers observed sustained intraocular pressure reduction and stable visual field measurements over 24 months. Success rates reached 86 percent for primary open-angle glaucoma and 81 percent for primary angle-closure glaucoma.
The players
International Journal of Ophthalmology
A medical publication that shares peer-reviewed research on eye health and ophthalmic surgical techniques.
Iridex
A medical device company that manufactures laser systems for the treatment of glaucoma and retinal diseases.
The details
The procedure uses the Iridex Cyclo G6 Laser and the MicroPulse P3 Delivery Device to regulate eye pressure. By delivering laser energy in a pulse-train format rather than a continuous wave, the device aims to manage fluid dynamics in the eye without causing thermal damage. This mechanism effectively lowers pressure, allowing patients to reduce their use of topical drops and eliminate the need for oral acetazolamide.
Timeline
The study follow-up occurred from 2024 to 2026.
Findings were published on October 12, 2026.
Health Landscape
This research adds to the clinical data surrounding the Iridex Cyclo G6 Laser platform as an alternative to traditional glaucoma management. It highlights a trend toward procedural interventions that aim to reduce the daily patient burden associated with chronic topical medication use.
If you are currently using multiple topical glaucoma medications, this research may be a helpful topic to discuss with your ophthalmologist. Ask your doctor about whether laser-based procedures are appropriate for your specific type of glaucoma and your overall treatment goals.
The takeaway
The study indicates that MicroPulse laser therapy can provide stable, long-term pressure control while lowering the need for daily glaucoma drops. Always consult your specialist to evaluate if your current eye pressure regimen needs adjustment or if you are a candidate for alternative procedures.
Further reading
Learn more about Stroke and other long-term management strategies for eye-related health complications.
Live Poll
Do you generally trust the findings of independent clinical studies for new medical treatment options?
